Vor Biopharma Inc. (VOR)

NASDAQ: VOR · Real-Time Price · USD

14.97

-0.04 (-0.27%)

At close: May 29, 2026, 4:00 PM EDT

14.89

-0.08 (-0.56%)

After-hours: May 29, 2026, 7:04 PM EDT

Vor Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	811	506	139	153	439	432
Market Cap Growth	3960.63%	265.67%	-9.35%	-65.19%	1.60%	-
Enterprise Value	322.57	53.97	74.19	47.43	244.27	240.68
Last Close Price	14.97	13.08	22.20	45.00	133.00	232.40
PB Ratio	-	-3.08	1.43	1.01	1.75	2.00
P/TBV Ratio	-1.90	-0.79	0.79	1.00	1.05	1.80
Debt / Equity Ratio	-0.02	-0.02	0.29	0.21	0.14	0.07
Net Debt / Equity Ratio	3.25	2.75	-0.62	-0.67	-0.76	-0.88
Net Debt / EBITDA Ratio	1.33	1.25	0.53	0.83	2.19	2.93
Net Debt / FCF Ratio	3.24	3.15	0.60	1.00	2.04	2.59
Quick Ratio	30.57	18.08	4.94	8.81	17.55	20.43
Current Ratio	31.15	18.20	5.19	9.04	18.06	21.12
Return on Equity (ROE)	561.16%	2057.65%	-94.52%	-58.74%	-39.45%	-52.09%
Return on Assets (ROA)	-76.94%	-122.45%	-71.07%	-50.67%	-34.47%	-43.34%
Return on Invested Capital (ROIC)	4521.38%	-3609.05%	-282.39%	-231.86%	-215.50%	-303.23%
Return on Capital Employed (ROCE)	-80.36%	-131.97%	-78.99%	-53.77%	-36.02%	-46.30%
Buyback Yield / Dilution	-359.89%	-187.35%	-2.26%	-69.89%	-18.30%	0.00%
Total Shareholder Return	-359.89%	-187.35%	-2.26%	-69.89%	-18.30%	0.00%

Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q